Efficacy and safety of elobixibat in hemodialysis patients with chronic constipation: a retrospective study
Abstract Background Hemodialysis patients are likely to develop constipation as a complication due to food and fluid restrictions. Elobixibat is a new laxative that inhibits the ileal bile acid transporter expressed in the terminal ileum, suppresses bile acid reabsorption, increases the amount of bi...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-04-01
|
Series: | Renal Replacement Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s41100-020-00267-y |